Affiliate Disclosure: PeptideOnline.co participates in affiliate programs. Some links are affiliate links — we may earn a commission at no extra cost to you. All recommendations are based on independent evaluation.
Why Cycling Matters
Not all peptides are meant to run continuously. Some need periodic breaks to prevent receptor desensitization, allow the body's natural systems to recalibrate, or simply because the research protocols they're based on were designed as cycles. Others work best as ongoing supplementation.
Getting this wrong can mean reduced effectiveness over time (the peptide "stops working") or unnecessary interruption of compounds that benefit from continuous use. This guide maps every major peptide to its optimal cycling strategy.
The Rule of Thumb: Peptides that stimulate receptor pathways (GH secretagogues, melanocortin agonists) generally benefit from cycling to prevent desensitization. Peptides that provide substrates or building blocks (NAD+, GHK-Cu topical) can often run continuously.
The Complete Cycling Reference
| Peptide | Cycle? | On Period | Off Period | Rationale |
|---|---|---|---|---|
| BPC-157 | Yes | 8-12 weeks | 4 weeks | Healing cascade has diminishing returns after 8-12 weeks. Off period allows reassessment. |
| TB-500 | Yes | Loading: 4 weeks, Maintenance: 4-8 weeks | 4+ weeks | Research protocols designed as finite courses, not continuous. |
| GHK-Cu (injectable) | Yes | 8-12 weeks | 4 weeks | Allows collagen remodeling to complete between cycles. |
| GHK-Cu (topical) | No | Continuous | N/A | Topical application doesn't create systemic receptor concerns. |
| Epitalon | Yes | 10-20 days | 4-6 months | Research protocol: short bursts to activate telomerase, then long rest periods. |
| CJC-1295/Ipamorelin | Optional | 12-16 weeks | 4-8 weeks | Some cycle to prevent potential GH receptor desensitization. Others run continuously with IGF-1 monitoring. |
| NAD+ (injectable) | No | Continuous | N/A | NAD+ is a metabolic substrate, not a receptor agonist. Continuous use maintains levels. |
| NAD+ (NMN/NR oral) | No | Continuous | N/A | Daily supplementation maintains elevated NAD+ levels. |
| Semaglutide/Tirzepatide | Provider-managed | Ongoing (therapeutic) | Taper, don't stop abruptly | Weight regain is common upon discontinuation. Medical supervision required. |
| Semax | Optional | 2-4 weeks | 1-2 weeks | Some cycle for sustained BDNF sensitivity. Others use as-needed. |
| Selank | Optional | 2-4 weeks | 1-2 weeks | Similar to Semax — some cycle, some run continuously for anxiety management. |
| Thymosin Alpha-1 | Optional | Ongoing or seasonal | N/A | Clinical use is often continuous (2x/week). Some use seasonally for immune support. |
| PT-141 | As-needed | Per use | 24+ hours between doses | Not meant for daily use. Max 8 doses/month per FDA labeling. |
| DSIP | Yes | 2-6 weeks | 2-4 weeks | Prevent potential habituation to sleep-promoting effects. |
| AOD-9604 | Yes | 8-12 weeks | 4 weeks | Reassess body composition changes, prevent plateau. |
| KPV | Flexible | 8-12 weeks | 4 weeks or as needed | Anti-inflammatory use can be cycled or continuous depending on condition. |
| MOTS-C | Flexible | 8-12 weeks | 4 weeks | Limited data on optimal cycling. Some run continuously. |
| FOX04-DRI | Yes | Short course (days-weeks) | Extended (months) | Senolytic therapy is inherently cyclical — clear senescent cells, then allow time for tissue renewal. |
Signs You Need to Cycle Off
- Diminishing effects: The peptide was working well initially but seems to have plateaued or stopped producing noticeable benefits
- New or worsening side effects: Side effects that weren't present earlier in the cycle appearing at week 8+
- Blood work changes: IGF-1 climbing above optimal range (GH peptides), inflammatory markers not improving as expected, or any other out-of-range values
- Protocol completion: You've achieved the healing/recovery goal the peptide was targeting (especially BPC-157, TB-500)
How to Structure Multi-Peptide Cycling
When running multiple peptides, stagger the on/off periods so you're not starting and stopping everything simultaneously:
- Start peptides one at a time (2-4 weeks apart) so you can identify what each one does
- Offset cycling schedules — if BPC-157 is 8 weeks on / 4 weeks off and CJC-1295 is 12 weeks on / 4 weeks off, start them at different times
- Continuous peptides (NAD+, GHK-Cu topical) can run as the backbone while you cycle targeted peptides around them
- Get blood work during the on-period (around week 6-8) and again at the end of the off-period to compare
Frequently Asked Questions
How long should you take BPC-157?
BPC-157 is typically cycled 8-12 weeks on, 4 weeks off. This allows the healing cascade to run its course and lets you reassess whether continued use is needed.
Can you take peptides continuously?
Some peptides are fine to run continuously — NAD+ (injectable or oral NMN/NR), GHK-Cu topical, and Thymosin Alpha-1 are commonly used without cycling. Others, especially GH secretagogues and receptor agonists, benefit from periodic breaks.
How long is an Epitalon cycle?
Epitalon follows the original Russian research protocol: 10-20 days of daily injections, then 4-6 months off. This cycle is repeated 2-3 times per year.
What happens if you don't cycle peptides?
Potential receptor desensitization — the peptide may become less effective over time as receptors downregulate. For healing peptides, continued use past the healing window provides diminishing returns.
Related Articles
Not Sure Which Peptide Is Right for You?
Take our free 60-second quiz and get personalized recommendations based on your goals.
Take the Quiz →